The effect of apolipoprotein B xbal polymorphism on plasma lipid response to dietary fat

European Journal of Clinical Investigation

Volumn 30, Issue 8, 2000, Pages 678-684

  Lopez Miranda J ^a,b   Marin C ^a   Castro, P ^a   Gomez P ^a   Gonzalez Amieva A ^a   Paz, E ^a   Bravo, D ^a   Ordovas, J M ^c,d   Jimenez Pereperez, J ^a   Perez Jimenez F ^a  

^a HOSPITAL UNIVERSITARIO REINA SOFÍA   (Spain)

^b HOSPITAL ALTO GUADALQUIVIR   (Spain)

^c TUFTS UNIVERSITY   (United States)

^d TUFTS UNIVERSITY   (United States)

Author keywords

Apolipoprotein B; Cholesterol; Diet; DNA polymorphism; LDL cholesterol; Triglycerides

Indexed keywords

APOLIPOPROTEIN B; CHOLESTEROL; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MONOUNSATURATED FATTY ACID; RESTRICTION ENDONUCLEASE; SATURATED FATTY ACID; TRIACYLGLYCEROL;

ADULT; ARTICLE; CHOLESTEROL INTAKE; CONTROLLED STUDY; FAT INTAKE; GENOTYPE; HUMAN; HUMAN EXPERIMENT; LIPID BLOOD LEVEL; MALE; NORMAL HUMAN; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; ALLELES; APOLIPOPROTEIN A-I; APOLIPOPROTEINS B; BODY MASS INDEX; CHOLESTEROL; DEOXYRIBONUCLEASES, TYPE II SITE-SPECIFIC; DIET RECORDS; DIETARY FATS; FATTY ACIDS; GENOTYPE; HUMANS; LIPIDS; MALE; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH;

EID: 0033865537     PISSN: 00142972     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2362.2000.00681.x     Document Type: Article

References (47)

1. 1 Miller GJ. High density lipoproteins and atherosclerosis. Annu Rev Med 1980;31:97-108.
2. 2 Kannel WB, Castelli WP, Gordon T. Cholesterol in the prediction of atherosclerosis disease. New perspectives based on the Framingham Study. Ann Intern Med 1979;90:85-91.
3. 3 Law MR, Wald NJ, Thompson SG. By how much and how quickly does reduction in serum cholesterol concentration lower risk of ischaemic heart disease? BMJ 1994;308:367.
4. 4 The Scandinavian Simvastatin Survival Study Group. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease. The Scandinavian Simvastatin Survival Study (4S). Lancet 1994;344:1383.
5. 5 Sacks FM, Pfeffer MA, Moye LA, Rouleau JL, Rutherford JD, Cole TG et al. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. N Engl J Med 1996;335:1001-9.
6. 6 Shepherd J, Cobbe SM, Ford I, Isles CG, Lorimer AR, Macfarlane PW et al. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. N Engl J Med 1995;333:1301-7.
7. 7 Katan MB, Beynen AC, de Vries JHM, Nobels A. Existence of consistent hypo-and hyperresponders to dietary cholesterol in man. Am J Epidemiol 1986;123:221.
8. 8 Beynen AC, Katan MB. Hypo-and hyperresponders to dietary cholesterol. Am J Clin Nutr 1986;43:974.
9. 9 Kane JP. Apolipoprotein B structural and metabolic heterogeneity. Annu Rev Physiol 1983;45:637-50.
10. 10 Olofsson SO, Bjursell G, Boström K, Carlsson P, Elovson J, Protter AA et al. Structure, biosynthesis and role in the lipoprotein assembly process. Atherosclerosis 1987;68:1-17.
11. 11 Deeb SS, Motulsky AG, Albers JJ. A partial cDNA clone for human apolipoprotein B. B Proc Nad Acad Sci 1985;82:4983-6.
12. 12 Knott TJ, Rall SG Jr, Innerarity TL, Jacobson SF, Urdea MS, Levy-Wilson B et al. Human apolipoprotein B structure of carboxyterminal domains, sites of gene-expression, and chromosomal localization. Science 1985;230:37-43.
13. 13 Law SW, Lackner KJ, Hospattankar AV, Anchors JM, Sakaguchi AY, Naylor SL et al. Human apolipoprotein B-100: clonig, analysis of liver mRNA, and assignment of the gene to chromosome 2. Proc Natl Acad Sci USA 1985;82:3240-8344.
14. 14 Law A, Wallis SC, Powell LM, Pease RJ, Brunt H, Priestley LM et al. Common DNA polymorphism within coding sequence of apolipoprotein B gene associated with altered lipid levels. Lancet 1986;i:1301-3.
15. 15 Berg K. DNA polymorphism at the apolipoprotein B locus is associated with lipoprotein level. Clin Genet 1986;30:515-20.
16. 16 Talmud PJ, Barni N, Kessling AM, Carlsson P, Darnfors G, Bjursell G et al. Apolipoprotein B gene variants are involved in the determination of serum cholesterol levels: a study in normo-and hyperlipidemic individuals. Atherosclerosis 1987;67:81-9.
17. 17 Aalto-Setälä K, Tikkanen M, Taskinen MR, Nieminen M, Homberg P, Kontula K. XbaI and c/g polymorphism of the apolipoprotein B gene locus are associated with serum cholesterol and LDL-cholesterol levels in Finland. Atherosclerosis 1988;74:47-54.
18. 18 Aalto-Setälä K, Viikari J, Dkerblom HK, Duusela V, Kontula K. DNA polymorphisms of the apolipoprotein B and A-I/ C-III genes are associated with variations of serum low density lipoprotein cholesterol level in childhood. J Lipid Res 1991;32:1477-87.
19. 19 Tikkanen MJ, Xu CF, Hämäläinen T, Talmud P, Sarna S, Huttunen JK et al. XbaI polymorphism of the apolipoprotein B gene influences plasma lipid response to diet intervention. Clin Genet 1990;37:327-34.
20. 20 Pajukanta PE, Valsta LM, Aro A, Pietinen P, Heliö T, Tikkanen MJ. The effects of the apolipoprotein B signal peptide (ins/del) and XbaI polymorphism on plasma lipid response to dietary change. Atherosclerosis 1996;122:1-10.
21. 21 Boerwinkle E, Brown SA, Rohrbach K, Gotto AM, Patsch W. Role of apolipoprotein E and B gene variation in determining response of lipid lipoprotein, and apolipoprotein levels to increased dietary cholesterol. Am J Hum Genet 1991;49:1145.
22. 22 Abbey M, Belling B, Clifton P, Nestel P. Apolipoprotein B gene polymorphism associates with plasma cholesterol changes induced by dietary fat and cholesterol. Nutr Metab Cardiovasc Dis 1991;1:10.
23. 23 Human Nutrition Information Service Department of Agriculture. Composition of foods. Agriculture Handbook N1 8 Washington DC: US Government Printing Office; 1987.
24. 24 Varela G. Food composition tables. Madrid: Instituto de Nutrición CSIC;1980.
25. 25 Rose HB, Oklander M. Improved procedure for the extraction of lipid from human erythrocytes. J Lipid Res 1965;6:428-31.
26. 26 Bucolo G, David H. Quantitative determination of serum triglycerides by use of enzymes. Clin Chem 1973;19:476-82.
27. 27 Allain CC, Poon LS, Chang CSG, Richmond W, Fu PC. Enzymatic determination of total serum cholesterol. Clin Chem 1974;20:470-5.
28. 28 Warnick GR, Benderson J, Albers JJ. Dextran sulfate-Mg+ precipitation procedure for quantitation of high density lipoprotein cholesterol. Clin Chim 1982;28:1379-88.
29. 29 Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma without use of preparative ultracentrifugue. Clin Chem 1972;18:499-502.
30. 30 Riepponen P, Marniemi J, Rautaoja T. Immunoturbidimetric determination of apolipoproteins A-I and B in serum. Scand J Clin Lab Invest 1987;47:739-44.
31. 31 Ordovas JM, Lopez-Miranda J, Mata P, Perez-Jimenez F, Lichtenstein AH, Schaefer EJ. Gene-diet interaction in determining plasma lipid response to dietary intervention. Atherosclerosis 1995;118 (Suppl.):S11-S27.
32. 32 Lopez-Miranda J, Ordovas JM, Espino A, Marin C, Salas J, Lopez-Segura F et al. Influence of mutation in human apolipoprotein A-1 gene promoter on plasma LDL cholesterol response to dietary fat. Lancet 1994;343:1246-9.
33. 33 Mata P, Ordovás JM, Lopez-Miranda J, Lichtenstein AH, Clevidence B, Judd JT et al. ApoA-IV phenotype affects diet-induced plasma LDL cholesterol lowering. Arterioscler Thromb 1994;14:884-91.
34. 34 McCombs RJ, Marcadis DE, Ellis J, Weinberg RB. Attenuated hypercholesterolemic response to a high-cholesterol diet in subjects heterozygous for the apolipoprotein A-IV-2 allele. N Engl J Med 1994;331:706-10.
35. 35 Lopez-Miranda J, Ordovas JM, Mata P, Lichtenstein AH, Clevidence B, Judd JT et al. Effect of apolipoprotein E phenotype on diet-induced lowering of plasma low density lipoprotein cholesterol. J Lipid Res 1994;35:1965-75.
36. 36 Tikkanen MJ, Huttunen JK, Enholm C, Pietinen P. Apolipoprotein E4 homozygosity predisposes to serum cholesterol elevation during high fat diet. Arteriosclerosis 1990;10:285-8.
37. 37 Denke MA. Review of human studies evaluating individual dietary responsiveness in patients with hypercholesterolemia. Am J Clin Nutr 1995;62:471S-7S.
38. 38 Carlsson P, Danrfors C, Olfsson S, Bjursell G. Analysis of the human apolipoprotein B gene: complete structure of the B74 region. Gene 1986;49:29-51.
39. 39 Berg K, Powell LM, Wallis C, Pease R, Knott JJ, Scott J. Genetic linkage between the antigenic grop (Ag) variation and the apolipoprotein B gene: assigment of the Ag locus. Proc Natl Acad Sci USA 1986;83:7367-70.
40. 40 Dunning AM, Tikkanen MJ, Ehnholm C, Bütler R, Humphries SE. Relationships between DNA and protein polymorphisms of apolipoprotein B. Hum Genet 1988;78:325-9.
41. 41 Demant T, Houlston RS, Caslake MJ, Series JJ, Shepherd J, Packard CJ et al. The catabolic rate of low density lipoprotein is influenced by variation in the apolipoprotein B gene. J Clin Invest 1988;82:797-802.
42. 42 Houlston RS, Turner PR, Revill J, Lewis B, Humphries SE. The fractional catabolic rate of low density lipoprotein in normal individuals in influenced by variation in the apolipoprotein B gene. Atherosclerosis 1988;71:81-5.
43. 43 Series J, Cameron I, Caslake M, Gaffney D, Packard CJ, Shepherd J. The XbaI polymorphism of the apolipoprotein B gene influences the degradation of low density lipoprotein in vitro. Biochim Biophys Acta 1989;1003:183-8.
44. 44 Peacock RE, Karpe F, Talmud PJ, Hamsten A, Humphries SE. Common variation in the gene for apolipoprotein B modulates postprandial lipoprotein metabolism: a hypothesis generating study. Atherosclerosis 1995;116:135-45.
45. 45 Chan L, Bradley WA. Signal peptides: properties and interactions: In: Conn PM, editor. Cellular Regulation of Secretion and Releas. New York: Academic Press;1982. p.301-21.
46. 46 Xu C-F, Tikkanen MJ, Huttunen JK, Pietinen P, Bütler R, Humphries S et al. Apolipoprotein B signal peptide insertion/ deletion polymorphism is associated with Ag epitopes and involved in the determination of serum triglyceride levels. J Lipid Res 1990;31:1255-61.
47. 47 Lopez-Miranda J, Orodovas JM, Ostos MA, Marin C, Jansen S, Salas J et al. Dietary fat clearance in normal subjects is modulated by genetic variation at the apolipoprotein B gene locus. Arterioscler Thromb Vasc Biol 1997;17:1765-73.